Daily Equity Report 25 SEP 2019

1. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. CapitalStars Investment Adviser: SEBI Registration Number: INA000001647 DAILY EQUITY REPORT 25THSEPTEMBER 2019 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

2. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. Daily Equity Report INDIAN FACE INDIAN MARKET CLOSE PREVIOUS ! INDIAN EQUITY BENCHMARK After two days of massive rally, the benchmark indices cooled off and ended flat on September 24 with Nifty below 11,600 level. At close, the Sensex was up 7.11 points at 39,097.14, while Nifty was CLOSE PREVIOUS down 12 points at 11,588.20. About 1169 shares have NIKKEI advanced, 1345 shares declined, and 147 shares are unchanged. Among sectors, bank, infra, metal and auto witnessed selling pressure, while buying seen in the IT, 2091.70 pharma, FMCG and energy stocks. GLOBAL FACE SECTORIAL INDICES CLOSE CHANGE (%) 11737.45 ! Asian Market - Asian markets finished higher today with shares in China leading the region. The Shanghai Composite is 9474.75 up 0.28% while Hong Kong's Hang Seng is up 0.23% and Japan's Nikkei 225 is up 0.09%. 4554.95 5994.90 ! 30183.10 U.S. Market - North and South American markets finished mixed to lower as of the most recent closing prices. Shares in TOP GAINERS Brazil fell as the Bo Vespa dropped 0.17%. The IPC lost 0.12% while the S&P 500 in U.S. closed unchanged. CLOSE CHANGE (%) 794.00 3.88 ! European markets European markets are mixed today. The CAC 40 is up 0.21% while the DAX gains 0.02%. The FTSE 100 281.55 3.66 TECHM 704.05 3.11 is off 0.10%. RELIANCE 1,277.50 3.09 TOP LOSERS CLOSE CHANGE (%) 233.50 -4.19 SBIN 301.00 -4.06 18,500.00 -3.84 703.15 -3.08 Daily Equity Report Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

3. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. NIFTY SPOT MARKET MOVERS UPSIDE STRATEGY CLOSE (%) 1.56 2047.30 TCS PIVOT POINTS P 11594 R1 R2 11710 458.35 1.66 11362 11478 11533 11469 11826 MARUTI 7033.20 1.96 S1-11533 S2-11478 R1-11469 R2-11710 HCLTECH 1049.10 1.57 MARKET MOVERS DOWNSIDE (%) -3.04 -3.08 ONGC -2.38 -4.06 NET FII 8373.74 BULLISH DII 9782.65 PIVOT POINTS P 30278 SUPPORT R1 30633 R3 31780 NSE TOTALS 28776 29527 29882 31029 RESISTANCE BANK NIFTY NIFTY 3 9 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

4. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. Daily Equity Report MARKET TALKS Kajaria Tiles gets NCLT nod for merger with Kajaria Ceramics Kajaria Ceramics announced on Tuesday that the Board of Directors of the Company has considered and approved the scheme of amalgamation for the merger of Kajaria Tiles Private Limited (Formerly known as Kajaria Floera Ceramics Private Limited), wholly-owned subsidiary of the Company with the Company, subject to requisite statutory and regulatory approvals under applicable laws including approval of the National Company Law Tribunal. Pennar Industries to double its CDW tubes capacity Shares Pennar Industries Limited, a leading value-added engineering products and solutions company today announced that it is doubling its Cold Drawn Welded (CDW) tubes manufacturing capacity. Pennar Industries is one of the leading suppliers of CDW tubes to Indiaâs automotive and construction equipment sectors. Pennar Industries will set up a Greenfield plant at Hyderabad for the additional CDW manufacturing capacity’s. Adani Enterprises incorporates Adani Guwahati International Airport Adani Enterprises Limited (AEL) has incorporated a Company namely "Adani Guwahati International Airport Limited" on 2nd September International Airport Limited will carry out the operations e. maintenance related activities of Lokpriya Gopinath Bordoloi International Airport located at Guwahati, Assam and is yet to commence its business operations. 2019.Adani Guwahati ! Suven Life Sciences jumps 4.5% after development in clinical trial for treatment of CNS disorders Suven Life Sciences, a clinical stage biopharmaceutical company developing novel medicines to treat life threatening Central Nervous System (CNS) disorders, announced dose administration of the first patient in a Phase 2A clinical trial of SUVN G-3031, a Histamine H3 receptor inverse agonist in a double-blind, placebo-controlled, parallel-group, multicenter study to evaluate the safety, tolerability, pharmacokinetics (PK), and efficacy of 2 mg and 4 mg SUVN-G3031 compared with placebo in patients with narcolepsy with and without cataplexy. Daily Equity Report Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

5. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. NAME OF THE STOCK : MUTHOOTFIN DATE : 25/09/2019 SEGMENT : CASH CHART TYPE : Candlestick : NSE : NSE EXCHANGE EXCHANGE TECHNICAL INDICATORS USED : VOLUME.MACD, RSI. CHART INVESTMENT ADVICE: CALL CS CALL:- BUY MUTHOOTFIN CASH ABOVE 690 TGT 705 SL 675 RATIONALE FOR ARRIVING INVESTMENT ADVICE : TECHNICAL VIEW : THE STOCK TECHINCALLY IS UP ,TAKING SUPPORT OF VOLUME.RESISTANCE IS BROKEN TODAY WITH HEAVY VOLUME.AS WELL AS A POSSIBILITY OF UPWARD MOVEMENT IS THERE. OTHER REASON IF ANY :- OTHER REASON IF ANY :- SHOWING STRENGTHS IN INTRADAY CHARTS AS WELL Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

6. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. DISCLAIMER The information and views in this report & all the service we provide are believed to be reliable, but we do not accept any responsibility for errors of fact or opinion. Investors have the right to choose the product/s that suits them the most. Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable. This material is for personal information and based upon it & takes no responsibility. The information given herein should be treated as only factor, while making investment decision. The report does not provide individually tailor-made investment advice. My research recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. CapitalStars shall not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules and regulations of regulators. The price projections shown are not necessarily indicative of future price performance. The information herein, together with all estimates and forecasts, can change without notice. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for. Investment & Trading in Securities Markets are always subjected to market risk. CapitalStars Financial Research Private Ltd., Reserves all Rights. INVESTMENT AND TRADING IN SECURITIES MARKET IS ALWAYS SUBJECTED TO MARKET RISK. Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

7. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. CapitalStars Financial Research Private Limited is an advisory company incepted with a vision of providing fair and accurate trading and investment calls in share and commodity market. we specialize in thorough fundamental and technical research analysis in equity and commodity market to provide best equity and commodity tips to traders and investors. we provide intraday as well as delivery stock tips in NSE and BSE and commodity tips in MCX and NCDEX. Get our more services:- Mcx Tips Financial advisory company Sharemarket company Stock Cash Intraday Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance. CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

8. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. BRANCH OFFICE Capitalstars Financial Research Private Limited PLOT NO.32, MECHANIC NAGAR EXTENSION,IDA SCHEME NO.54,VIJAYNAGAR INDORE REGISTERED OFFICE PLOT NO.12, SCHEME NO.78 PART-2, VIJAY NAGAR, INDORE Email:-backoffice@capiltalstars.in Contact us :- 9977499927, 9039012727 Report Is Checked by Investment Advisor: Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.